230 related articles for article (PubMed ID: 35539431)
1. Chronic activation of MUC1-C in wound repair promotes progression to cancer stem cells.
Kufe DW
J Cancer Metastasis Treat; 2022; 8():. PubMed ID: 35539431
[TBL] [Abstract][Full Text] [Related]
2. Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer.
Kufe D
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835130
[TBL] [Abstract][Full Text] [Related]
3. MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells.
Bhattacharya A; Fushimi A; Yamashita N; Hagiwara M; Morimoto Y; Rajabi H; Long MD; Abdulla M; Ahmad R; Street K; Liu S; Liu T; Kufe D
Mol Cancer Res; 2022 Apr; 20(4):556-567. PubMed ID: 35022313
[TBL] [Abstract][Full Text] [Related]
4. MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells.
Hagiwara M; Fushimi A; Yamashita N; Bhattacharya A; Rajabi H; Long MD; Yasumizu Y; Oya M; Liu S; Kufe D
Oncogene; 2021 Jul; 40(30):4930-4940. PubMed ID: 34163028
[TBL] [Abstract][Full Text] [Related]
5. MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells.
Hagiwara M; Yasumizu Y; Yamashita N; Rajabi H; Fushimi A; Long MD; Li W; Bhattacharya A; Ahmad R; Oya M; Liu S; Kufe D
Cancer Res; 2021 Feb; 81(4):1111-1122. PubMed ID: 33323379
[TBL] [Abstract][Full Text] [Related]
6. MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells.
Rajabi H; Hiraki M; Kufe D
Oncogene; 2018 Apr; 37(16):2079-2088. PubMed ID: 29379165
[TBL] [Abstract][Full Text] [Related]
7. Emergence of
Kufe DW
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230728
[TBL] [Abstract][Full Text] [Related]
8. Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer Progression.
Yamashita N; Kufe D
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897789
[TBL] [Abstract][Full Text] [Related]
9. MUC1-C regulates NEAT1 lncRNA expression and paraspeckle formation in cancer progression.
Bhattacharya A; Wang K; Penailillo J; Chan CN; Fushimi A; Yamashita N; Daimon T; Haratake N; Ozawa H; Nakashoji A; Shigeta K; Morimoto Y; Miyo M; Kufe DW
Oncogene; 2024 May; ():. PubMed ID: 38802648
[TBL] [Abstract][Full Text] [Related]
10. MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells.
Hata T; Rajabi H; Takahashi H; Yasumizu Y; Li W; Jin C; Long MD; Hu Q; Liu S; Fushimi A; Yamashita N; Kui L; Hong D; Yamamoto M; Miyo M; Hiraki M; Maeda T; Suzuki Y; Samur MK; Kufe D
Cancer Res; 2019 Nov; 79(22):5711-5722. PubMed ID: 31519689
[TBL] [Abstract][Full Text] [Related]
11. MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression.
Bhattacharya A; Fushimi A; Wang K; Yamashita N; Morimoto Y; Ishikawa S; Daimon T; Liu T; Liu S; Long MD; Kufe D
Commun Biol; 2023 Oct; 6(1):1030. PubMed ID: 37821650
[TBL] [Abstract][Full Text] [Related]
12. MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer.
Yamashita N; Morimoto Y; Fushimi A; Ahmad R; Bhattacharya A; Daimon T; Haratake N; Inoue Y; Ishikawa S; Yamamoto M; Hata T; Akiyoshi S; Hu Q; Liu T; Withers H; Liu S; Shapiro GI; Yoshizumi T; Long MD; Kufe D
Mol Cancer Res; 2023 Mar; 21(3):274-289. PubMed ID: 36445328
[TBL] [Abstract][Full Text] [Related]
13. SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus.
Kia SK; Gorski MM; Giannakopoulos S; Verrijzer CP
Mol Cell Biol; 2008 May; 28(10):3457-64. PubMed ID: 18332116
[TBL] [Abstract][Full Text] [Related]
14. MUC1-C Oncoprotein Integrates a Program of EMT, Epigenetic Reprogramming and Immune Evasion in Human Carcinomas.
Rajabi H; Kufe D
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):117-122. PubMed ID: 28302417
[TBL] [Abstract][Full Text] [Related]
15. MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer.
Hagiwara M; Fushimi A; Bhattacharya A; Yamashita N; Morimoto Y; Oya M; Withers HG; Hu Q; Liu T; Liu S; Wong KK; Long MD; Kufe D
Oncoimmunology; 2022; 11(1):2029298. PubMed ID: 35127252
[TBL] [Abstract][Full Text] [Related]
16. DOC1-Dependent Recruitment of NURD Reveals Antagonism with SWI/SNF during Epithelial-Mesenchymal Transition in Oral Cancer Cells.
Mohd-Sarip A; Teeuwssen M; Bot AG; De Herdt MJ; Willems SM; Baatenburg de Jong RJ; Looijenga LHJ; Zatreanu D; Bezstarosti K; van Riet J; Oole E; van Ijcken WFJ; van de Werken HJG; Demmers JA; Fodde R; Verrijzer CP
Cell Rep; 2017 Jul; 20(1):61-75. PubMed ID: 28683324
[TBL] [Abstract][Full Text] [Related]
17. Differential Modulation of Polycomb-Associated Histone Marks by cBAF, pBAF, and gBAF Complexes.
Bergwell M; Park J; Kirkland JG
bioRxiv; 2024 Jan; ():. PubMed ID: 37790495
[TBL] [Abstract][Full Text] [Related]
18. MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia.
Tagde A; Rajabi H; Stroopinsky D; Gali R; Alam M; Bouillez A; Kharbanda S; Stone R; Avigan D; Kufe D
Oncotarget; 2016 Jun; 7(26):38974-38987. PubMed ID: 27259275
[TBL] [Abstract][Full Text] [Related]
19. MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells.
Yamashita N; Withers H; Morimoto Y; Bhattacharya A; Haratake N; Daimon T; Fushimi A; Nakashoji A; Thorner AR; Isenhart E; Rosario S; Long MD; Kufe D
iScience; 2023 Nov; 26(11):108168. PubMed ID: 37915591
[TBL] [Abstract][Full Text] [Related]
20. The chromatin-remodeling subunit Baf200 promotes homology-directed DNA repair and regulates distinct chromatin-remodeling complexes.
de Castro RO; Previato L; Goitea V; Felberg A; Guiraldelli MF; Filiberti A; Pezza RJ
J Biol Chem; 2017 May; 292(20):8459-8471. PubMed ID: 28381560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
